Learn about the negative correlation coefficient, its significance, comparison with other coefficients, and real-world ...
Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutation Phase 2 results presented at 2025 San Antonio Breast Cancer Symposium ...
This time last year, managed service provider (MSP) Iomart was hitting the headlines for making a game-changing acquisition, a move that has made a positive impact on the bottom line in the 12 months ...
Results from the BRUIN CLL-314 study comparing Jaypirca (pirtobrutinib) to Imbruvica (ibrutinib) – the first-ever head-to-head Phase 3 study versus a covalent BTK inhibitor to include treatment-naïve ...
The latest update is out from Apogee Therapeutics ( (APGE)). On November 10, 2025, Apogee Therapeutics announced positive interim Phase 1 results for APG333, which exceeded trial objectives and ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Phio Pharmaceuticals ( (PHIO)) just ...
Retailers across the country are adjusting to the U.S. Treasury's decision to phase out penny production.Some stores have started asking customers to use exact change as they continue to assess the ...
This power-management tip introduces the two different circuits for a positive-to-negative voltage conversion and a negative-to-positive voltage conversion. However, there are times when a voltage ...
Pfizer's oncology portfolio has produced a second positive phase 3 trial in HER2-positive breast cancer in the span of about a year. This time, the drug that delivered the positive readout is Tukysa, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback